Showing posts with label decline. Show all posts
Showing posts with label decline. Show all posts

Wednesday, February 26, 2014

Another Reason Why There Was A Decline In U S Hospitalizations for Heart Failure

By now, many Disease Management Care Blog readers have become aware of this JAMA research study that used Medicare fee-for-service claims data to examine the nationwide rate of hospitalizations for chronic heart failure.  From 1998 to 2008, there was a counterintuitive 30% decline in the U.S. from a baseline rate of 2845 to a new rate of 2007 admissions per 100,000 person-years. 

The authors credit better care of heart attacks (damage from a heart attack to can lead to a flabby dilated heart), better prevention (such as more aggressive treatment of high blood pressure, which also causes heart damage) and a more "effective" medical system (such as better outpatient follow-up, use of alternate levels of care, flu shots prescriptions of ACE inhibitors and beta blocker medications).  The authors of the study think the numbers are remarkable because the U.S. population is getting older and healthier persons (without heart failure) seem to be signing up for managed care Medicare Advantage.

The DMCB is wondering about another possibility that has nothing to do with epidemiology or quality.  Rather, it could be the impact of Medicare payment rates on billing patterns.  After all, if heart failure is the leading Medicare inpatient diagnosis, shouldnt a decrease there have an impact on the overall hospitalization rate?

The DMCB explains:

When beneficiaries are discharged from a hospital, the bill (or the claim) submitted to Medicare is based on a "Diagnosis Related Group."  While the invention and logic of DRGs complicated, theyre important because the principal diagnosis determines the amount of the global payment for that hospitalization. While this may be overly simplistic, a discharge with a diagnosis of "heart failure" prompts Medicare to pay a hospital "X" dollars, while a diagnosis of pneumonia or kidney failure will render payments of "Y" and "Z" dollars, respectively.  In general, the more complicated the diagnosis, the greater the payment.

All well and good, but suppose the hospital has a patient with several concurrent problems and has a choice on which DRG to use?  As anyone who has taken care of hospitalized patients knows, there are usually multiple diagnoses present in any patient at one time.  Pneumonia may or may not have provoked the heart attack that led to the kidney failure that led to the leg swelling and the shortness of breath.  Given three simultaneous diagnoses, Medicare billing guidelines state that the hospital should use their best judgement to determine which DRG to bill. All things being equal, smart hospitals will probably use the DRG that renders the greatest payment.

The DMCB isnt saying that fraudulent billing (for example) accounts for the decrease in heart failure hospitalizations for Medicare. However, it knows some diagnosis related groups can be less remunerative than others and that in the last ten years, DRG payment rates have evolved and that hospitals have learned how to "code" more accurately and aggressively.  Based on the example at the bottom of this page, the DMCB wonders if some patients that were diagnosed with heart failure in 1988 would have been diagnosed with something more remunerative in 2007. 

In other words, there may have been the same number of hospitalizations involving the same patients with the same disease burden.  It was the case mix that changed?

The authors of the study to their credit cant discount the possibility:  They argue that if coding had changed there would have been a shift in the mortality rate of patients with heart failure:

"We were unable to determine whether the observed changes were due to changes by hospitals in medical coding; however, substantial up-coding or down-coding would likely result in changes to the coefficients of the CMS HF mortality model, and these coefficients remained stable from 2005 to 2008."

The authors may have a point, but that assumes the modeling - also based on claims - is trustworthy.

Of course, there is no way, based on Medicare billing claims alone, to determine whether measurement also played a role in the decline in heart failure admissions.  That would take an audit of the medical records themselves.

Sunday, September 15, 2013

Vitamin B6 Deficit Promotes Inflammation Heart Disease and Cognitive Decline

As cardiovascular disease continues to take the lives of millions of unsuspecting individuals worldwide, a continual stream of scientific evidence is emerging to show that many who suffer from this illness could be spared by relatively simple dietary and lifestyle interventions. Prior studies have shown that low vitamin B6 (pyridoxal-5-phosphate (PLP)) status are the root cause behind most inflammatory diseases, including cardiovascular disease, rheumatoid arthritis, inflammatory bowel disease, and diabetes and new research indicates that vitamin B6 and B12 deficiencies are linked to cognitive decline and depression.

Researchers reporting in The Journal of Nutrition from the U.S. Department of Agriculture Human Nutrition Research Center at Tufts University in Boston have now provided conclusive evidence that low levels of vitamin B6 significantly increases the risk for diseases mediated by systemic inflammation, with special emphasis on the leading cause of mortality in the US, cardiovascular disease. Including natural foods such as leafy greens (spinach and kale), seeds and nuts to your diet may go a long way to cut the risks associated with heart disease, loss of cognition and early death.
heart disease and cognitive decline

Vitamins B6 and B12 are essential to prevent cognitive decline and depression

Researchers examined 2,229 men and women as part of the Framingham Offspring study and found that those individuals with the lowest plasma levels of vitamin B6, experienced the highest rise in circulating inflammatory markers. The study monitored 13 individual inflammatory markers, including interleukin-6, tumor necrosis factor alpha and intercellular adhesion molecule-1, each known to be an independent risk factor in increased risk of inflammation and cardiovascular disease in particular.

Additional evidence supporting the importance of B vitamins is presented in The Journal of Nutrition to demonstrate that both vitamin B6 and B12 are essential to prevent cognitive decline and team together to provide natural relief from depression. Prior studies have demonstrated that supplementation with both B vitamins lowers damaging levels of the amino acid homocysteine and are associated with improvements in a range of mental tests including global cognition and spatial memory.

Using questionnaires to assess dietary and health factors, researchers analyzed the data to determine that low vitamin B12 concentrations were associated with higher scores to assess degree of depression and low B6 status related to poor mental status, a measure of cognitive abilities. The full spectrum of B vitamins are essential to energy metabolism in the human body and the latest research confirms that a well-balanced diet and daily supplementation can help prevent a range of chronic, debilitating conditions including heart disease, dementia and depression.

Sources for this article include:

http://jn.nutrition.org
http://www.medpagetoday.com/Cardiology/Prevention/33532
http://jn.nutrition.org
http://www.nutraingredients.com